Acadia Healthcare Company, Inc. (ACHC)
NASDAQ: ACHC · Real-Time Price · USD
27.91
-0.18 (-0.64%)
At close: Sep 28, 2026, 4:00 PM EDT
27.91
0.00 (0.00%)
After-hours: Sep 28, 2026, 4:15 PM EDT
Acadia Healthcare Company Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Acadia Healthcare Company stock has a consensus rating of "Buy" and an average price target of $33.79. The average 1-year stock price forecast is 21.07% higher than the current stock price, while the lowest is $17 (-39.09%) and the highest is $41 (+46.90%).
Price Target: $33.79 (+21.07%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Acadia Healthcare Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 7 | 7 | 7 | 7 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 6 | 6 | 5 | 5 | 5 | 5 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Maintains $39 | Buy | Maintains | $39 | +39.73% | Sep 28, 2026 |
| Leerink Partners | Leerink Partners | Hold Reiterates $30 → $33 | Hold | Reiterates | $30 → $33 | +18.24% | Sep 23, 2026 |
| Jefferies | Jefferies | Buy Maintains $40 | Buy | Maintains | $40 | +43.32% | Sep 17, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Maintains n/a | Sell | Maintains | n/a | n/a | Sep 14, 2026 |
| Barclays | Barclays | Hold Maintains $32 | Hold | Maintains | $32 | +14.65% | Aug 28, 2026 |
Financial Forecast
Revenue This Year
3.43B
from 3.31B
Increased by 3.48%
Revenue Next Year
3.63B
from 3.43B
Increased by 5.84%
EPS This Year
1.55
from 2.00
Decreased by -22.36%
EPS Next Year
1.85
from 1.55
Increased by 18.93%
EPS and Forward PE are based on non-GAAP adjusted numbers.